An experimental Covid vaccine from Australia joined almost two dozen candidates in clinical trials this week. Development-wise, it’s months behind some of the frontrunners. Jason Gale explains that speed isn’t everything when it comes to fighting the pandemic.
 Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

An experimental Covid vaccine from Australia joined almost two dozen candidates in clinical trials this week. Development-wise, it’s months behind some of the frontrunners. Jason Gale explains that speed isn’t everything when it comes to fighting the pandemic. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

The First Vaccine May Not Be the Best

On Breakthrough, a new series from the Prognosis podcast, we explore how the pandemic is changing our understanding of healthcare and medicine. We start with an examination of long Covid, a mysterious new illness that has stumped doctors attempting to treat symptoms that last for months and potentially years. It has changed the way hospitals work and forced healthcare officials to prepare for the next pandemic. Covid has also opened the door to revolutionary technology: messenger RNA vaccines. It’s a technology that never could have been proven so quickly outside the crucible of that first pandemic year, 2020, and it holds big implications for the future of medicine.

Share The First Vaccine May Not Be the Best

Sign up to save your podcasts

The First Vaccine May Not Be the Best

The First Vaccine May Not Be the Best